MARIANI PETER J Insider Trading Activity

Average Profitability
19.13%
Insider Buys Quantity
4
Insider Buys Sum
$97,263.84
Insider Sells Quantity
9
Insider Sells Sum
$2.32M

Insider Activity of MARIANI PETER J

According to the SEC Form 4 filings, MARIANI PETER J, being in a position of

  1. Chief Financial Officer at Cytosorbents Corporation,
    оver the last 12 months, has bought 100000 shares for $44,000, and sold 0 shares,
    over all time since 2024-12-11, has bought 151363 shares for $91,269, and sold 0 shares.

Biography of MARIANI PETER J

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$44,0001100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2026-06-15PurchaseCytosorbents Corporation
CTSO
Chief Financial Officer
100,000
0.1622%
$0.44$44,000-18.52%
2024-12-13PurchaseCytosorbents Corporation
CTSO
Chief Financial Officer
20,000
0.0335%
$0.96$19,294-3.76%
2024-12-12PurchaseCytosorbents Corporation
CTSO
Chief Financial Officer
20,000
0.0369%
$0.89$17,872+9.26%
2024-12-11PurchaseCytosorbents Corporation
CTSO
Chief Financial Officer
11,363
0.0201%
$0.89$10,103+10.56%
2023-12-11SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
12,500
0.0291%
$7.50$93,809+19.6%
2023-02-01SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
14,550
0.0348%
$9.36$136,188-11.3%
2023-01-31SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
14,320
0.0343%
$9.55$136,756-12.99%
2023-01-30SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
14,111
0.0334%
$9.69$136,736-15.31%
2023-01-27SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
20,940
0.0495%
$10.16$212,750-19.34%
2022-11-16SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
10,649
0.027%
$11.88$126,510-24.3%
2020-12-29SaleAxoGen, Inc.
AXGN
Chief Financial Officer
2,586
0.0033%
$8.90$23,028+8.43%
2020-12-21SaleAxoGen, Inc.
AXGN
Chief Financial Officer
962
0.0023%
$16.42$15,796+11.1%
2020-10-30SaleAxoGen, Inc.
AXGN
Chief Financial Officer
151,366
0.285%
$9.49$1.44M+50.52%
2016-10-07PurchaseAxoGen, Inc.
AXGN
Chief Financial Officer
6,666
0.0168%
$7.50$49,995+19.13%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.